HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Hyperlipidemia in the elderly].

Abstract
Many studies show hypercholesterolemia is an even stronger risk factor for coronary heart disease(CHD) in the elderly, and most studies evaluated ischemic strokes separately show a positive association with cholesterol levels. Large prevention studies show HMG-CoA reductase inhibitors significantly decreased major coronary events in the elderly similar to that observed in the younger people, and were also effective in preventing ischemic stroke. For primary prevention, therapeutic life-style change is the first line of therapy for the elderly. However, LDL-lowering drugs can be considered when they are at established CHD, higher risk because of multiple risk factors, or advanced subclinical atherosclerosis. The association of triglycerides level or HDL-cholesterol level and atherosclerotic diseases has been well defined in the elderly.
AuthorsMikihiko Kawano
JournalNihon rinsho. Japanese journal of clinical medicine (Nihon Rinsho) Vol. 60 Issue 5 Pg. 1017-23 (May 2002) ISSN: 0047-1852 [Print] Japan
PMID12029980 (Publication Type: English Abstract, Journal Article, Review)
Chemical References
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypolipidemic Agents
Topics
  • Aged
  • Coronary Disease (prevention & control)
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors (therapeutic use)
  • Hypercholesterolemia (drug therapy)
  • Hyperlipidemias (drug therapy)
  • Hypolipidemic Agents (therapeutic use)
  • Male

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: